Drug Metabolism & Biotransformation

active metabolite

An active metabolite is a leftover from metabolism that still does pharmacological work. We usually picture metabolism as switching a drug off, but sometimes the breakdown product keeps acting on the target — like a candle that, after the wick burns down, leaves a glowing ember that continues to give off heat.

Chemically, an active metabolite arises when an enzyme modifies the parent drug into a new molecule that still binds the same target, or even a different one, with meaningful potency. It may be more or less potent than the parent, may have a longer or shorter half-life, and may have its own distribution and side-effect profile. In the special case where the parent is inactive and the metabolite carries all the activity, the parent is a prodrug.

Active metabolites matter because the observed effect of a drug can be the sum of the parent and its metabolites. A long-lived active metabolite can extend the duration of action well beyond the parent's own half-life, but it can also drive interactions and toxicity that would be missed if only the parent were measured. Drug developers therefore identify and characterize significant active metabolites as part of the safety picture.

Codeine is largely a prodrug: CYP2D6 converts a small fraction of it to morphine, the active metabolite responsible for most of its pain relief, which is why people with different CYP2D6 activity respond so differently.

An active metabolite carrying the real pharmacology.